The global Implanted Urinary Incontinence Device market size was valued at US$ 1230 million in 2024 and is forecast to a readjusted size of USD 2070 million by 2031 with a CAGR of 7.8% during review period.
Urinary incontinence is the involuntary loss of urine due to a loss of bladder control. Millions of people across the world are affected by urinary incontinence, and women are more likely to be affected than men. Urinary incontinence is highly underreported, primarily due to embarrassment to speak about it. Several factors such as urinary tract infection, weakening of the pelvic floor muscles and urethral sphincters, menopause, pregnancy and childbirth, and post radical prostatectomy surgery in men lead to the development of urinary incontinence.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report is a detailed and comprehensive analysis for global Implanted Urinary Incontinence Device market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Implanted Urinary Incontinence Device market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Implanted Urinary Incontinence Device market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Implanted Urinary Incontinence Device market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Implanted Urinary Incontinence Device market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Implanted Urinary Incontinence Device
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Implanted Urinary Incontinence Device market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Boston Scientific, GT Urological, RBM-Med, ZEPHYR Surgical Implants, Albyn Medical, Implantica, Medtronic, InControl Medical, Atlantic Therapeutics Group, Axonics Modulation Technologies, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Implanted Urinary Incontinence Device market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Artificial Urinary Sphincters
Electrical Stimulation Devices
Others
Market segment by Application
Hospitals and Clinics
Ambulatory Surgery Centres
Others
Major players covered
Boston Scientific
GT Urological
RBM-Med
ZEPHYR Surgical Implants
Albyn Medical
Implantica
Medtronic
InControl Medical
Atlantic Therapeutics Group
Axonics Modulation Technologies
Laborie
Micron Medical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Implanted Urinary Incontinence Device product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Implanted Urinary Incontinence Device, with price, sales quantity, revenue, and global market share of Implanted Urinary Incontinence Device from 2020 to 2025.
Chapter 3, the Implanted Urinary Incontinence Device competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Implanted Urinary Incontinence Device breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Implanted Urinary Incontinence Device market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Implanted Urinary Incontinence Device.
Chapter 14 and 15, to describe Implanted Urinary Incontinence Device sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Implanted Urinary Incontinence Device Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Artificial Urinary Sphincters
1.3.3 Electrical Stimulation Devices
1.3.4 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Implanted Urinary Incontinence Device Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Hospitals and Clinics
1.4.3 Ambulatory Surgery Centres
1.4.4 Others
1.5 Global Implanted Urinary Incontinence Device Market Size & Forecast
1.5.1 Global Implanted Urinary Incontinence Device Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Implanted Urinary Incontinence Device Sales Quantity (2020-2031)
1.5.3 Global Implanted Urinary Incontinence Device Average Price (2020-2031)
2 Manufacturers Profiles
2.1 Boston Scientific
2.1.1 Boston Scientific Details
2.1.2 Boston Scientific Major Business
2.1.3 Boston Scientific Implanted Urinary Incontinence Device Product and Services
2.1.4 Boston Scientific Implanted Urinary Incontinence Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Boston Scientific Recent Developments/Updates
2.2 GT Urological
2.2.1 GT Urological Details
2.2.2 GT Urological Major Business
2.2.3 GT Urological Implanted Urinary Incontinence Device Product and Services
2.2.4 GT Urological Implanted Urinary Incontinence Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 GT Urological Recent Developments/Updates
2.3 RBM-Med
2.3.1 RBM-Med Details
2.3.2 RBM-Med Major Business
2.3.3 RBM-Med Implanted Urinary Incontinence Device Product and Services
2.3.4 RBM-Med Implanted Urinary Incontinence Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 RBM-Med Recent Developments/Updates
2.4 ZEPHYR Surgical Implants
2.4.1 ZEPHYR Surgical Implants Details
2.4.2 ZEPHYR Surgical Implants Major Business
2.4.3 ZEPHYR Surgical Implants Implanted Urinary Incontinence Device Product and Services
2.4.4 ZEPHYR Surgical Implants Implanted Urinary Incontinence Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 ZEPHYR Surgical Implants Recent Developments/Updates
2.5 Albyn Medical
2.5.1 Albyn Medical Details
2.5.2 Albyn Medical Major Business
2.5.3 Albyn Medical Implanted Urinary Incontinence Device Product and Services
2.5.4 Albyn Medical Implanted Urinary Incontinence Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Albyn Medical Recent Developments/Updates
2.6 Implantica
2.6.1 Implantica Details
2.6.2 Implantica Major Business
2.6.3 Implantica Implanted Urinary Incontinence Device Product and Services
2.6.4 Implantica Implanted Urinary Incontinence Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Implantica Recent Developments/Updates
2.7 Medtronic
2.7.1 Medtronic Details
2.7.2 Medtronic Major Business
2.7.3 Medtronic Implanted Urinary Incontinence Device Product and Services
2.7.4 Medtronic Implanted Urinary Incontinence Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Medtronic Recent Developments/Updates
2.8 InControl Medical
2.8.1 InControl Medical Details
2.8.2 InControl Medical Major Business
2.8.3 InControl Medical Implanted Urinary Incontinence Device Product and Services
2.8.4 InControl Medical Implanted Urinary Incontinence Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 InControl Medical Recent Developments/Updates
2.9 Atlantic Therapeutics Group
2.9.1 Atlantic Therapeutics Group Details
2.9.2 Atlantic Therapeutics Group Major Business
2.9.3 Atlantic Therapeutics Group Implanted Urinary Incontinence Device Product and Services
2.9.4 Atlantic Therapeutics Group Implanted Urinary Incontinence Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Atlantic Therapeutics Group Recent Developments/Updates
2.10 Axonics Modulation Technologies
2.10.1 Axonics Modulation Technologies Details
2.10.2 Axonics Modulation Technologies Major Business
2.10.3 Axonics Modulation Technologies Implanted Urinary Incontinence Device Product and Services
2.10.4 Axonics Modulation Technologies Implanted Urinary Incontinence Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Axonics Modulation Technologies Recent Developments/Updates
2.11 Laborie
2.11.1 Laborie Details
2.11.2 Laborie Major Business
2.11.3 Laborie Implanted Urinary Incontinence Device Product and Services
2.11.4 Laborie Implanted Urinary Incontinence Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Laborie Recent Developments/Updates
2.12 Micron Medical
2.12.1 Micron Medical Details
2.12.2 Micron Medical Major Business
2.12.3 Micron Medical Implanted Urinary Incontinence Device Product and Services
2.12.4 Micron Medical Implanted Urinary Incontinence Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Micron Medical Recent Developments/Updates
3 Competitive Environment: Implanted Urinary Incontinence Device by Manufacturer
3.1 Global Implanted Urinary Incontinence Device Sales Quantity by Manufacturer (2020-2025)
3.2 Global Implanted Urinary Incontinence Device Revenue by Manufacturer (2020-2025)
3.3 Global Implanted Urinary Incontinence Device Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Implanted Urinary Incontinence Device by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Implanted Urinary Incontinence Device Manufacturer Market Share in 2024
3.4.3 Top 6 Implanted Urinary Incontinence Device Manufacturer Market Share in 2024
3.5 Implanted Urinary Incontinence Device Market: Overall Company Footprint Analysis
3.5.1 Implanted Urinary Incontinence Device Market: Region Footprint
3.5.2 Implanted Urinary Incontinence Device Market: Company Product Type Footprint
3.5.3 Implanted Urinary Incontinence Device Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Implanted Urinary Incontinence Device Market Size by Region
4.1.1 Global Implanted Urinary Incontinence Device Sales Quantity by Region (2020-2031)
4.1.2 Global Implanted Urinary Incontinence Device Consumption Value by Region (2020-2031)
4.1.3 Global Implanted Urinary Incontinence Device Average Price by Region (2020-2031)
4.2 North America Implanted Urinary Incontinence Device Consumption Value (2020-2031)
4.3 Europe Implanted Urinary Incontinence Device Consumption Value (2020-2031)
4.4 Asia-Pacific Implanted Urinary Incontinence Device Consumption Value (2020-2031)
4.5 South America Implanted Urinary Incontinence Device Consumption Value (2020-2031)
4.6 Middle East & Africa Implanted Urinary Incontinence Device Consumption Value (2020-2031)
5 Market Segment by Type
5.1 Global Implanted Urinary Incontinence Device Sales Quantity by Type (2020-2031)
5.2 Global Implanted Urinary Incontinence Device Consumption Value by Type (2020-2031)
5.3 Global Implanted Urinary Incontinence Device Average Price by Type (2020-2031)
6 Market Segment by Application
6.1 Global Implanted Urinary Incontinence Device Sales Quantity by Application (2020-2031)
6.2 Global Implanted Urinary Incontinence Device Consumption Value by Application (2020-2031)
6.3 Global Implanted Urinary Incontinence Device Average Price by Application (2020-2031)
7 North America
7.1 North America Implanted Urinary Incontinence Device Sales Quantity by Type (2020-2031)
7.2 North America Implanted Urinary Incontinence Device Sales Quantity by Application (2020-2031)
7.3 North America Implanted Urinary Incontinence Device Market Size by Country
7.3.1 North America Implanted Urinary Incontinence Device Sales Quantity by Country (2020-2031)
7.3.2 North America Implanted Urinary Incontinence Device Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 Europe
8.1 Europe Implanted Urinary Incontinence Device Sales Quantity by Type (2020-2031)
8.2 Europe Implanted Urinary Incontinence Device Sales Quantity by Application (2020-2031)
8.3 Europe Implanted Urinary Incontinence Device Market Size by Country
8.3.1 Europe Implanted Urinary Incontinence Device Sales Quantity by Country (2020-2031)
8.3.2 Europe Implanted Urinary Incontinence Device Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 Asia-Pacific
9.1 Asia-Pacific Implanted Urinary Incontinence Device Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Implanted Urinary Incontinence Device Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Implanted Urinary Incontinence Device Market Size by Region
9.3.1 Asia-Pacific Implanted Urinary Incontinence Device Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Implanted Urinary Incontinence Device Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 South America
10.1 South America Implanted Urinary Incontinence Device Sales Quantity by Type (2020-2031)
10.2 South America Implanted Urinary Incontinence Device Sales Quantity by Application (2020-2031)
10.3 South America Implanted Urinary Incontinence Device Market Size by Country
10.3.1 South America Implanted Urinary Incontinence Device Sales Quantity by Country (2020-2031)
10.3.2 South America Implanted Urinary Incontinence Device Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 Middle East & Africa
11.1 Middle East & Africa Implanted Urinary Incontinence Device Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Implanted Urinary Incontinence Device Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Implanted Urinary Incontinence Device Market Size by Country
11.3.1 Middle East & Africa Implanted Urinary Incontinence Device Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Implanted Urinary Incontinence Device Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 Market Dynamics
12.1 Implanted Urinary Incontinence Device Market Drivers
12.2 Implanted Urinary Incontinence Device Market Restraints
12.3 Implanted Urinary Incontinence Device Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Implanted Urinary Incontinence Device and Key Manufacturers
13.2 Manufacturing Costs Percentage of Implanted Urinary Incontinence Device
13.3 Implanted Urinary Incontinence Device Production Process
13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Implanted Urinary Incontinence Device Typical Distributors
14.3 Implanted Urinary Incontinence Device Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Boston Scientific
GT Urological
RBM-Med
ZEPHYR Surgical Implants
Albyn Medical
Implantica
Medtronic
InControl Medical
Atlantic Therapeutics Group
Axonics Modulation Technologies
Laborie
Micron Medical
听
听
*If Applicable.